Jani, A. B., Schreibmann, E., Goyal, S., Halkar, R., Hershatter, B., Rossi, P. J., Shelton, J. W., Patel, P. R., Xu, K. M., Goodman, M., Master, V. A., Joshi, S. S., Kucuk, O., Carthon, B. C., Bilen, M. A., Abiodun-Ojo, O. A., Akintayo, A. A., Dhere, V. R., & Schuster, D. M. (2021). 18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial. Lancet, 397(10288), 1895–1904. http://access.bl.uk/ark:/81055/vdc_100130755939.0x000051